| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acute Kidney Injury | 67 | 2023 | 880 | 8.100 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 26 | 2024 | 244 | 6.390 |
Why?
|
| Polycystic Kidney Diseases | 15 | 2025 | 82 | 6.300 |
Why?
|
| Kidney | 49 | 2025 | 1511 | 5.330 |
Why?
|
| Cisplatin | 14 | 2020 | 347 | 4.140 |
Why?
|
| Autophagy | 14 | 2024 | 291 | 3.170 |
Why?
|
| TOR Serine-Threonine Kinases | 12 | 2025 | 456 | 3.050 |
Why?
|
| Interleukin-18 | 22 | 2019 | 234 | 2.820 |
Why?
|
| TRPP Cation Channels | 12 | 2024 | 76 | 2.650 |
Why?
|
| Kidney Tubules, Proximal | 22 | 2015 | 129 | 2.590 |
Why?
|
| Sirolimus | 8 | 2019 | 283 | 2.150 |
Why?
|
| Caspase 1 | 17 | 2019 | 145 | 2.140 |
Why?
|
| Disease Models, Animal | 26 | 2025 | 4605 | 2.010 |
Why?
|
| Kidney Tubules | 16 | 2019 | 118 | 2.000 |
Why?
|
| Apoptosis | 32 | 2020 | 2454 | 1.970 |
Why?
|
| Caspases | 16 | 2019 | 233 | 1.790 |
Why?
|
| Calpain | 18 | 2006 | 61 | 1.690 |
Why?
|
| Kidney Diseases | 9 | 2022 | 428 | 1.580 |
Why?
|
| Kidney Tubular Necrosis, Acute | 6 | 2015 | 26 | 1.420 |
Why?
|
| Cell Proliferation | 11 | 2024 | 2529 | 1.420 |
Why?
|
| Animals | 112 | 2025 | 38417 | 1.410 |
Why?
|
| Antineoplastic Agents | 9 | 2019 | 2231 | 1.400 |
Why?
|
| Mice, Inbred C57BL | 37 | 2025 | 6042 | 1.370 |
Why?
|
| Caspase Inhibitors | 12 | 2019 | 81 | 1.290 |
Why?
|
| Caspase 3 | 19 | 2016 | 242 | 1.280 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2020 | 984 | 1.190 |
Why?
|
| Cysts | 4 | 2024 | 112 | 1.150 |
Why?
|
| Mice | 54 | 2025 | 18493 | 1.090 |
Why?
|
| Biomarkers | 33 | 2023 | 4354 | 1.090 |
Why?
|
| Acute-Phase Proteins | 14 | 2019 | 66 | 1.080 |
Why?
|
| Lipocalins | 13 | 2019 | 35 | 1.080 |
Why?
|
| Ischemia | 11 | 2019 | 424 | 1.070 |
Why?
|
| Reperfusion Injury | 7 | 2011 | 294 | 0.930 |
Why?
|
| Nephrectomy | 5 | 2021 | 172 | 0.920 |
Why?
|
| Immunosuppressive Agents | 7 | 2018 | 840 | 0.890 |
Why?
|
| Rats | 28 | 2024 | 5613 | 0.890 |
Why?
|
| Cytokines | 10 | 2024 | 2087 | 0.860 |
Why?
|
| Lymphoid Tissue | 1 | 2025 | 81 | 0.860 |
Why?
|
| Autophagy-Related Proteins | 3 | 2021 | 46 | 0.850 |
Why?
|
| Urate Oxidase | 1 | 2024 | 12 | 0.830 |
Why?
|
| Deoxyglucose | 1 | 2024 | 51 | 0.830 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2014 | 122 | 0.810 |
Why?
|
| Hypertension | 8 | 2022 | 1280 | 0.810 |
Why?
|
| Hibernation | 3 | 2016 | 82 | 0.800 |
Why?
|
| Lipocalin-2 | 15 | 2020 | 80 | 0.770 |
Why?
|
| Necrosis | 6 | 2014 | 245 | 0.770 |
Why?
|
| Interleukin-1beta | 5 | 2019 | 394 | 0.770 |
Why?
|
| Male | 93 | 2025 | 73954 | 0.750 |
Why?
|
| Uric Acid | 1 | 2024 | 168 | 0.750 |
Why?
|
| Interleukin-33 | 4 | 2017 | 45 | 0.730 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2022 | 28 | 0.720 |
Why?
|
| Renal Insufficiency | 2 | 2023 | 172 | 0.720 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2022 | 76 | 0.690 |
Why?
|
| Blood Urea Nitrogen | 8 | 2020 | 53 | 0.680 |
Why?
|
| Proto-Oncogene Proteins | 11 | 2013 | 627 | 0.670 |
Why?
|
| Cysteine Proteinase Inhibitors | 7 | 2008 | 49 | 0.660 |
Why?
|
| Kidney Transplantation | 8 | 2018 | 732 | 0.650 |
Why?
|
| Lovastatin | 2 | 2013 | 37 | 0.640 |
Why?
|
| Piperidines | 1 | 2022 | 224 | 0.640 |
Why?
|
| Trehalose | 1 | 2020 | 35 | 0.630 |
Why?
|
| Amino Acid Chloromethyl Ketones | 5 | 2014 | 24 | 0.620 |
Why?
|
| Chemokine CX3CL1 | 3 | 2011 | 25 | 0.610 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2020 | 126 | 0.610 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 430 | 0.610 |
Why?
|
| Adenine | 1 | 2022 | 339 | 0.600 |
Why?
|
| Apolipoproteins | 6 | 2017 | 38 | 0.600 |
Why?
|
| Metformin | 1 | 2023 | 329 | 0.600 |
Why?
|
| Naphthyridines | 1 | 2019 | 20 | 0.590 |
Why?
|
| Cardiac Surgical Procedures | 10 | 2017 | 616 | 0.580 |
Why?
|
| Organ Preservation | 4 | 2015 | 127 | 0.580 |
Why?
|
| Interleukin-6 | 9 | 2019 | 784 | 0.580 |
Why?
|
| Protein Kinase C | 1 | 2020 | 251 | 0.580 |
Why?
|
| Cardiomegaly | 1 | 2020 | 175 | 0.570 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 633 | 0.560 |
Why?
|
| Mice, Knockout | 14 | 2025 | 3153 | 0.560 |
Why?
|
| Chemokine CXCL1 | 6 | 2015 | 76 | 0.550 |
Why?
|
| Endothelial Cells | 5 | 2022 | 886 | 0.540 |
Why?
|
| Cold Ischemia | 3 | 2015 | 40 | 0.530 |
Why?
|
| Humans | 99 | 2024 | 147306 | 0.530 |
Why?
|
| Mice, Mutant Strains | 7 | 2019 | 303 | 0.520 |
Why?
|
| Interleukin-1alpha | 2 | 2014 | 57 | 0.510 |
Why?
|
| Inflammation Mediators | 5 | 2021 | 507 | 0.500 |
Why?
|
| Rats, Sprague-Dawley | 16 | 2024 | 2542 | 0.500 |
Why?
|
| Creatinine | 12 | 2015 | 516 | 0.490 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2015 | 1162 | 0.480 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 267 | 0.480 |
Why?
|
| Macrophages | 5 | 2013 | 1530 | 0.480 |
Why?
|
| Quinolines | 3 | 2014 | 192 | 0.480 |
Why?
|
| Lipoprotein(a) | 6 | 2001 | 70 | 0.470 |
Why?
|
| Interleukins | 3 | 2014 | 248 | 0.470 |
Why?
|
| Epithelial Cells | 5 | 2019 | 1141 | 0.470 |
Why?
|
| Renin-Angiotensin System | 3 | 2013 | 80 | 0.470 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 6 | 2008 | 230 | 0.460 |
Why?
|
| Hypoxia | 12 | 2000 | 1209 | 0.460 |
Why?
|
| Phenylenediamines | 1 | 2015 | 14 | 0.460 |
Why?
|
| Mutation | 2 | 2019 | 4130 | 0.460 |
Why?
|
| Cystatin C | 6 | 2019 | 66 | 0.450 |
Why?
|
| Genetic Therapy | 2 | 2014 | 317 | 0.450 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 4 | 2013 | 448 | 0.440 |
Why?
|
| Carrier Proteins | 4 | 2014 | 731 | 0.440 |
Why?
|
| Angiotensinogen | 1 | 2014 | 4 | 0.440 |
Why?
|
| Neutrophil Infiltration | 4 | 2013 | 107 | 0.430 |
Why?
|
| Sciuridae | 2 | 2016 | 152 | 0.420 |
Why?
|
| Interleukin-8 | 2 | 2013 | 269 | 0.410 |
Why?
|
| Phenanthrenes | 1 | 2014 | 12 | 0.410 |
Why?
|
| Diterpenes | 1 | 2014 | 26 | 0.410 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2011 | 300 | 0.400 |
Why?
|
| Lung Injury | 2 | 2015 | 262 | 0.400 |
Why?
|
| Transcriptional Activation | 1 | 2015 | 372 | 0.390 |
Why?
|
| Purines | 1 | 2014 | 188 | 0.390 |
Why?
|
| Enalapril | 4 | 2007 | 16 | 0.380 |
Why?
|
| Kidney Function Tests | 5 | 2015 | 156 | 0.380 |
Why?
|
| Lymphocyte Depletion | 3 | 2015 | 133 | 0.380 |
Why?
|
| Tumor Burden | 3 | 2020 | 327 | 0.360 |
Why?
|
| Kidney Failure, Chronic | 5 | 2015 | 600 | 0.360 |
Why?
|
| Oxidative Stress | 3 | 2019 | 1368 | 0.360 |
Why?
|
| Cysteine Endopeptidases | 6 | 2006 | 80 | 0.360 |
Why?
|
| Proteinuria | 4 | 2022 | 104 | 0.360 |
Why?
|
| Calcium | 9 | 2000 | 1197 | 0.350 |
Why?
|
| Signal Transduction | 9 | 2021 | 5272 | 0.350 |
Why?
|
| Cells, Cultured | 10 | 2019 | 4170 | 0.350 |
Why?
|
| Reperfusion | 1 | 2011 | 54 | 0.350 |
Why?
|
| Enzyme Inhibitors | 4 | 2024 | 822 | 0.350 |
Why?
|
| NF-kappa B | 1 | 2015 | 676 | 0.350 |
Why?
|
| Immunoblotting | 6 | 2014 | 296 | 0.340 |
Why?
|
| Diuretics | 3 | 2007 | 68 | 0.340 |
Why?
|
| Peroxidase | 5 | 2015 | 168 | 0.330 |
Why?
|
| Phosphorylation | 5 | 2019 | 1721 | 0.330 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 3 | 2021 | 138 | 0.330 |
Why?
|
| Endotoxemia | 4 | 2005 | 86 | 0.330 |
Why?
|
| Glomerular Filtration Rate | 8 | 2024 | 765 | 0.320 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2015 | 1225 | 0.320 |
Why?
|
| Indoles | 1 | 2014 | 510 | 0.320 |
Why?
|
| Liver Diseases | 2 | 2011 | 307 | 0.310 |
Why?
|
| Neutrophils | 5 | 2007 | 1135 | 0.310 |
Why?
|
| Female | 46 | 2024 | 80081 | 0.310 |
Why?
|
| Kringles | 3 | 1999 | 5 | 0.310 |
Why?
|
| Delayed Graft Function | 3 | 2014 | 54 | 0.310 |
Why?
|
| Interleukin-1 | 5 | 2015 | 961 | 0.300 |
Why?
|
| Renal Replacement Therapy | 3 | 2012 | 104 | 0.300 |
Why?
|
| Adaptation, Physiological | 2 | 2013 | 568 | 0.300 |
Why?
|
| Postoperative Complications | 10 | 2017 | 3022 | 0.300 |
Why?
|
| Protein Kinases | 2 | 2008 | 312 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2019 | 440 | 0.290 |
Why?
|
| L-Lactate Dehydrogenase | 9 | 2007 | 112 | 0.290 |
Why?
|
| Disease Progression | 9 | 2014 | 2892 | 0.290 |
Why?
|
| AIDS-Associated Nephropathy | 1 | 2008 | 7 | 0.280 |
Why?
|
| Drug Design | 1 | 2010 | 177 | 0.280 |
Why?
|
| Drug Delivery Systems | 2 | 2010 | 381 | 0.280 |
Why?
|
| Macrophages, Peritoneal | 1 | 2009 | 89 | 0.280 |
Why?
|
| Complement Factor B | 3 | 2023 | 106 | 0.280 |
Why?
|
| Polycystic Kidney, Autosomal Recessive | 1 | 2008 | 6 | 0.280 |
Why?
|
| Dendritic Cells | 1 | 2012 | 510 | 0.270 |
Why?
|
| CD11b Antigen | 4 | 2009 | 60 | 0.270 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 2 | 2021 | 62 | 0.270 |
Why?
|
| Receptors, Chemokine | 1 | 2007 | 48 | 0.260 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2021 | 174 | 0.260 |
Why?
|
| Lung Neoplasms | 2 | 2020 | 2679 | 0.260 |
Why?
|
| Nephrosis, Lipoid | 1 | 2007 | 10 | 0.260 |
Why?
|
| Liver Transplantation | 2 | 2013 | 841 | 0.260 |
Why?
|
| Nephrology | 1 | 2008 | 61 | 0.260 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2008 | 130 | 0.260 |
Why?
|
| Nitric Oxide Synthase | 9 | 2001 | 234 | 0.260 |
Why?
|
| Blotting, Western | 8 | 2012 | 1186 | 0.260 |
Why?
|
| Ionomycin | 4 | 2000 | 22 | 0.260 |
Why?
|
| Nitric Oxide | 13 | 2007 | 892 | 0.260 |
Why?
|
| Apolipoproteins A | 4 | 2001 | 19 | 0.250 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 109 | 0.250 |
Why?
|
| Pyrimidinones | 2 | 2020 | 125 | 0.250 |
Why?
|
| Gene Deletion | 2 | 2008 | 392 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 376 | 0.250 |
Why?
|
| Peptide Hydrolases | 3 | 2009 | 105 | 0.240 |
Why?
|
| Critical Illness | 6 | 2023 | 907 | 0.240 |
Why?
|
| Biological Assay | 3 | 2021 | 134 | 0.230 |
Why?
|
| Fatty Acid-Binding Proteins | 2 | 2019 | 79 | 0.230 |
Why?
|
| Cell Line | 7 | 2021 | 2832 | 0.230 |
Why?
|
| Autophagy-Related Protein 7 | 1 | 2025 | 13 | 0.230 |
Why?
|
| Regulatory-Associated Protein of mTOR | 1 | 2025 | 24 | 0.220 |
Why?
|
| Rewarming | 2 | 2016 | 22 | 0.220 |
Why?
|
| Prospective Studies | 19 | 2023 | 8166 | 0.220 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 308 | 0.220 |
Why?
|
| Cell Membrane | 2 | 2007 | 711 | 0.220 |
Why?
|
| Cold Temperature | 4 | 2016 | 207 | 0.220 |
Why?
|
| Albuminuria | 3 | 2019 | 189 | 0.220 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2019 | 167 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2019 | 2030 | 0.220 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2022 | 124 | 0.220 |
Why?
|
| Blood Pressure | 8 | 2022 | 1785 | 0.220 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2015 | 264 | 0.210 |
Why?
|
| Oxypurinol | 1 | 2024 | 3 | 0.210 |
Why?
|
| Kidney Cortex | 3 | 2004 | 27 | 0.210 |
Why?
|
| Oxonic Acid | 1 | 2024 | 13 | 0.210 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 2974 | 0.210 |
Why?
|
| Chemokines | 3 | 2010 | 217 | 0.200 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2006 | 220 | 0.200 |
Why?
|
| Xanthine Oxidase | 1 | 2024 | 79 | 0.200 |
Why?
|
| Neoplasms | 2 | 2019 | 2946 | 0.200 |
Why?
|
| Organ Size | 3 | 2010 | 465 | 0.200 |
Why?
|
| Lysosomes | 2 | 2021 | 133 | 0.200 |
Why?
|
| Phospholipases A | 6 | 2001 | 97 | 0.200 |
Why?
|
| Lactates | 1 | 2023 | 82 | 0.200 |
Why?
|
| Renal Circulation | 5 | 2013 | 75 | 0.190 |
Why?
|
| Ionophores | 2 | 2000 | 24 | 0.190 |
Why?
|
| Hepatitis A Virus Cellular Receptor 1 | 3 | 2019 | 43 | 0.190 |
Why?
|
| Leukocyte Elastase | 3 | 1999 | 75 | 0.190 |
Why?
|
| Metalloendopeptidases | 2 | 2001 | 63 | 0.190 |
Why?
|
| Predictive Value of Tests | 8 | 2016 | 2133 | 0.190 |
Why?
|
| Inflammasomes | 1 | 2024 | 145 | 0.180 |
Why?
|
| Apolipoproteins B | 2 | 2001 | 48 | 0.180 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2019 | 459 | 0.180 |
Why?
|
| Middle Aged | 26 | 2018 | 36821 | 0.180 |
Why?
|
| Adult | 26 | 2024 | 41406 | 0.180 |
Why?
|
| RNA, Messenger | 6 | 2014 | 2812 | 0.180 |
Why?
|
| Hospitalization | 1 | 2013 | 2496 | 0.180 |
Why?
|
| Time Factors | 9 | 2017 | 7173 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2011 | 365 | 0.180 |
Why?
|
| Kidney Glomerulus | 3 | 2011 | 125 | 0.180 |
Why?
|
| Lipoproteins, HDL | 3 | 2017 | 104 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2023 | 192 | 0.180 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 74 | 0.180 |
Why?
|
| Cathepsin B | 3 | 2005 | 17 | 0.170 |
Why?
|
| Body Temperature | 2 | 2013 | 229 | 0.170 |
Why?
|
| Peptide Fragments | 4 | 2000 | 698 | 0.170 |
Why?
|
| Multiprotein Complexes | 2 | 2014 | 172 | 0.170 |
Why?
|
| Oxidants | 1 | 2001 | 99 | 0.170 |
Why?
|
| Mice, Transgenic | 5 | 2012 | 2197 | 0.160 |
Why?
|
| Autophagy-Related Protein 12 | 1 | 2020 | 4 | 0.160 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2020 | 8 | 0.160 |
Why?
|
| Caspase 8 | 3 | 2005 | 48 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 241 | 0.160 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2015 | 153 | 0.160 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 8432 | 0.160 |
Why?
|
| Cathepsins | 3 | 1996 | 24 | 0.160 |
Why?
|
| Butadienes | 1 | 2020 | 33 | 0.160 |
Why?
|
| Chloroquine | 1 | 2020 | 54 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2013 | 849 | 0.150 |
Why?
|
| Prognosis | 9 | 2016 | 4384 | 0.150 |
Why?
|
| Case-Control Studies | 5 | 2017 | 3660 | 0.150 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2019 | 23 | 0.150 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2020 | 76 | 0.150 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2005 | 120 | 0.150 |
Why?
|
| Body Weight | 3 | 2010 | 976 | 0.150 |
Why?
|
| Hospital Mortality | 3 | 2016 | 1043 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2022 | 552 | 0.150 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 65 | 0.150 |
Why?
|
| Models, Animal | 2 | 2011 | 394 | 0.150 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2019 | 26 | 0.150 |
Why?
|
| Trefoil Factor-3 | 1 | 2019 | 5 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2001 | 482 | 0.150 |
Why?
|
| Netrin-1 | 1 | 2019 | 17 | 0.150 |
Why?
|
| Antidiuretic Hormone Receptor Antagonists | 2 | 2010 | 10 | 0.150 |
Why?
|
| Clusterin | 1 | 2019 | 12 | 0.150 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 2019 | 14 | 0.150 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2016 | 46 | 0.140 |
Why?
|
| beta 2-Microglobulin | 1 | 2019 | 48 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 222 | 0.140 |
Why?
|
| Early Diagnosis | 4 | 2013 | 254 | 0.140 |
Why?
|
| ErbB Receptors | 1 | 2022 | 638 | 0.140 |
Why?
|
| Heart Failure, Diastolic | 1 | 2019 | 23 | 0.140 |
Why?
|
| Cardio-Renal Syndrome | 1 | 2019 | 20 | 0.140 |
Why?
|
| Membrane Glycoproteins | 3 | 2013 | 499 | 0.140 |
Why?
|
| Proteins | 3 | 2013 | 1024 | 0.140 |
Why?
|
| Nitriles | 1 | 2020 | 211 | 0.140 |
Why?
|
| Acute Lung Injury | 2 | 2012 | 312 | 0.140 |
Why?
|
| Inflammation | 1 | 2010 | 2921 | 0.140 |
Why?
|
| Pyridones | 1 | 2020 | 210 | 0.130 |
Why?
|
| Glycine | 3 | 1997 | 186 | 0.130 |
Why?
|
| Metabolomics | 2 | 2021 | 737 | 0.130 |
Why?
|
| Oncogene Proteins | 2 | 2015 | 62 | 0.130 |
Why?
|
| Exosomes | 1 | 2019 | 104 | 0.130 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2011 | 187 | 0.130 |
Why?
|
| In Vitro Techniques | 6 | 2000 | 1049 | 0.130 |
Why?
|
| Flow Cytometry | 3 | 2011 | 1172 | 0.130 |
Why?
|
| Renal Dialysis | 3 | 2011 | 467 | 0.130 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 2017 | 3 | 0.130 |
Why?
|
| bcl-X Protein | 2 | 2011 | 45 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 288 | 0.130 |
Why?
|
| Urinalysis | 1 | 2017 | 83 | 0.130 |
Why?
|
| Endopeptidases | 2 | 1995 | 80 | 0.120 |
Why?
|
| Pilot Projects | 2 | 2024 | 1912 | 0.120 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 445 | 0.120 |
Why?
|
| Chlorophyta | 2 | 2009 | 11 | 0.120 |
Why?
|
| Cyclosporine | 3 | 2012 | 257 | 0.120 |
Why?
|
| Perfusion | 2 | 2011 | 252 | 0.120 |
Why?
|
| T-Box Domain Proteins | 1 | 2017 | 106 | 0.120 |
Why?
|
| Aged | 16 | 2017 | 26516 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2010 | 445 | 0.120 |
Why?
|
| Glycosaminoglycans | 1 | 2016 | 79 | 0.120 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2014 | 24 | 0.120 |
Why?
|
| Heart | 3 | 2019 | 628 | 0.120 |
Why?
|
| Swine | 6 | 2019 | 828 | 0.120 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2015 | 15 | 0.120 |
Why?
|
| Thiones | 1 | 2015 | 13 | 0.120 |
Why?
|
| Antibodies | 4 | 2012 | 398 | 0.110 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2015 | 22 | 0.110 |
Why?
|
| Cell Hypoxia | 3 | 2007 | 249 | 0.110 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2016 | 70 | 0.110 |
Why?
|
| Caspase 2 | 2 | 2006 | 12 | 0.110 |
Why?
|
| Immunohistochemistry | 3 | 2005 | 1730 | 0.110 |
Why?
|
| Spectrin | 3 | 2000 | 14 | 0.110 |
Why?
|
| Heterozygote | 2 | 2007 | 317 | 0.110 |
Why?
|
| Homozygote | 1 | 2015 | 199 | 0.110 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 122 | 0.110 |
Why?
|
| Child | 9 | 2023 | 22980 | 0.110 |
Why?
|
| Shock, Septic | 2 | 2016 | 230 | 0.110 |
Why?
|
| CD36 Antigens | 1 | 2014 | 32 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 387 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
|
| Survival Rate | 2 | 2011 | 2110 | 0.110 |
Why?
|
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2015 | 24 | 0.110 |
Why?
|
| Apoprotein(a) | 4 | 1999 | 8 | 0.110 |
Why?
|
| Furosemide | 2 | 2007 | 37 | 0.110 |
Why?
|
| Substrate Specificity | 3 | 2000 | 387 | 0.110 |
Why?
|
| Caspase 9 | 2 | 2004 | 55 | 0.110 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2014 | 17 | 0.100 |
Why?
|
| Protective Agents | 1 | 2014 | 43 | 0.100 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2014 | 27 | 0.100 |
Why?
|
| Interleukin-12 | 1 | 2014 | 115 | 0.100 |
Why?
|
| Epoxy Compounds | 1 | 2014 | 31 | 0.100 |
Why?
|
| Incidence | 2 | 2013 | 2954 | 0.100 |
Why?
|
| Clinical Trials as Topic | 2 | 2010 | 1072 | 0.100 |
Why?
|
| Phospholipases A2 | 5 | 2001 | 79 | 0.100 |
Why?
|
| Mice, Inbred BALB C | 2 | 2012 | 1266 | 0.100 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 76 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 373 | 0.090 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2012 | 31 | 0.090 |
Why?
|
| Acute Disease | 3 | 2012 | 1049 | 0.090 |
Why?
|
| Dogs | 1 | 2014 | 518 | 0.090 |
Why?
|
| Down-Regulation | 1 | 2014 | 618 | 0.090 |
Why?
|
| Glomerulonephritis | 1 | 1992 | 44 | 0.090 |
Why?
|
| Acrylates | 3 | 2006 | 48 | 0.090 |
Why?
|
| Risk Factors | 8 | 2017 | 11017 | 0.090 |
Why?
|
| Cilia | 1 | 2013 | 173 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 673 | 0.090 |
Why?
|
| Fibrosis | 1 | 2014 | 568 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 475 | 0.090 |
Why?
|
| Clodronic Acid | 1 | 2012 | 19 | 0.090 |
Why?
|
| Research Design | 1 | 2018 | 1158 | 0.090 |
Why?
|
| Diphtheria Toxin | 1 | 2012 | 65 | 0.090 |
Why?
|
| Amino Acid Sequence | 5 | 1999 | 2134 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2014 | 2625 | 0.090 |
Why?
|
| Heart Diseases | 2 | 2013 | 341 | 0.090 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 112 | 0.090 |
Why?
|
| Amlodipine | 2 | 2002 | 10 | 0.090 |
Why?
|
| Pandemics | 1 | 2020 | 1720 | 0.080 |
Why?
|
| Beclin-1 | 1 | 2011 | 11 | 0.080 |
Why?
|
| Raffinose | 1 | 2011 | 29 | 0.080 |
Why?
|
| Area Under Curve | 4 | 2013 | 334 | 0.080 |
Why?
|
| Arousal | 1 | 2011 | 158 | 0.080 |
Why?
|
| Warm Ischemia | 1 | 2011 | 28 | 0.080 |
Why?
|
| Allopurinol | 1 | 2011 | 70 | 0.080 |
Why?
|
| Sus scrofa | 1 | 2011 | 66 | 0.080 |
Why?
|
| Ribosomal Protein S6 | 1 | 2010 | 18 | 0.080 |
Why?
|
| Organ Preservation Solutions | 1 | 2011 | 46 | 0.080 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2012 | 161 | 0.080 |
Why?
|
| Nucleosides | 1 | 2010 | 25 | 0.080 |
Why?
|
| Matrix Metalloproteinase 12 | 2 | 2001 | 7 | 0.080 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 156 | 0.080 |
Why?
|
| Protein Kinase C-alpha | 1 | 2010 | 37 | 0.080 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2011 | 78 | 0.080 |
Why?
|
| Cell Fractionation | 2 | 2000 | 50 | 0.080 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2010 | 88 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2014 | 724 | 0.080 |
Why?
|
| Cell Movement | 2 | 2007 | 966 | 0.080 |
Why?
|
| Death | 1 | 2011 | 132 | 0.080 |
Why?
|
| Rats, Mutant Strains | 2 | 2012 | 19 | 0.080 |
Why?
|
| Coumarins | 2 | 2000 | 16 | 0.080 |
Why?
|
| Lipoproteins, LDL | 2 | 2001 | 119 | 0.080 |
Why?
|
| Protein Precursors | 3 | 1985 | 136 | 0.080 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 1496 | 0.080 |
Why?
|
| Nucleotides | 1 | 2010 | 129 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 197 | 0.080 |
Why?
|
| Intensive Care Units | 3 | 2017 | 928 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2016 | 11947 | 0.070 |
Why?
|
| Pancreatic Elastase | 2 | 2001 | 54 | 0.070 |
Why?
|
| Adenosine | 1 | 2011 | 255 | 0.070 |
Why?
|
| Seasons | 1 | 2011 | 540 | 0.070 |
Why?
|
| Pneumonia | 2 | 2012 | 636 | 0.070 |
Why?
|
| Glutathione | 1 | 2011 | 370 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 1999 | 2886 | 0.070 |
Why?
|
| Respiration, Artificial | 2 | 2016 | 717 | 0.070 |
Why?
|
| Image Enhancement | 1 | 2010 | 201 | 0.070 |
Why?
|
| Cell Adhesion Molecules | 1 | 2010 | 182 | 0.070 |
Why?
|
| DNA Fragmentation | 2 | 2009 | 43 | 0.070 |
Why?
|
| Toll-Like Receptors | 1 | 2010 | 193 | 0.070 |
Why?
|
| Immunity, Cellular | 1 | 2010 | 280 | 0.070 |
Why?
|
| Macrophages, Alveolar | 1 | 2011 | 377 | 0.070 |
Why?
|
| Adoptive Transfer | 1 | 2009 | 200 | 0.070 |
Why?
|
| Dipeptides | 2 | 2001 | 56 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 2000 | 762 | 0.070 |
Why?
|
| Endothelium, Vascular | 2 | 2007 | 959 | 0.070 |
Why?
|
| Lung Diseases | 1 | 1995 | 787 | 0.070 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 282 | 0.070 |
Why?
|
| Octreotide | 1 | 2008 | 23 | 0.070 |
Why?
|
| Diagnosis, Differential | 2 | 2011 | 1518 | 0.070 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2007 | 19 | 0.070 |
Why?
|
| Benzazepines | 1 | 2008 | 35 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 2458 | 0.070 |
Why?
|
| Antimycin A | 1 | 2007 | 14 | 0.070 |
Why?
|
| Calcium Channel Blockers | 2 | 2000 | 166 | 0.070 |
Why?
|
| Sensitivity and Specificity | 1 | 2013 | 2017 | 0.070 |
Why?
|
| Superoxides | 3 | 1999 | 199 | 0.070 |
Why?
|
| Cell Count | 1 | 2008 | 321 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 3 | 2006 | 1514 | 0.070 |
Why?
|
| Growth Hormone | 1 | 2008 | 91 | 0.070 |
Why?
|
| Oligopeptides | 2 | 2000 | 267 | 0.070 |
Why?
|
| Comorbidity | 1 | 2013 | 1672 | 0.070 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2007 | 50 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 977 | 0.070 |
Why?
|
| Lisinopril | 1 | 2007 | 15 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 269 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 1999 | 362 | 0.060 |
Why?
|
| Rats, Inbred Strains | 1 | 2007 | 323 | 0.060 |
Why?
|
| gamma-Glutamyltransferase | 3 | 2012 | 43 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2011 | 427 | 0.060 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2008 | 116 | 0.060 |
Why?
|
| Estradiol | 1 | 2011 | 515 | 0.060 |
Why?
|
| von Willebrand Factor | 1 | 2007 | 85 | 0.060 |
Why?
|
| Environment | 1 | 2009 | 297 | 0.060 |
Why?
|
| Sequence Analysis | 2 | 1997 | 34 | 0.060 |
Why?
|
| Adolescent | 6 | 2013 | 22826 | 0.060 |
Why?
|
| Cytoprotection | 2 | 2015 | 56 | 0.060 |
Why?
|
| Fibrinogen | 2 | 1999 | 180 | 0.060 |
Why?
|
| RNA, Catalytic | 1 | 2007 | 191 | 0.060 |
Why?
|
| Colorado | 2 | 2016 | 4591 | 0.060 |
Why?
|
| Prednisone | 1 | 2007 | 230 | 0.060 |
Why?
|
| Complement System Proteins | 1 | 2010 | 322 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2010 | 590 | 0.060 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 1997 | 48 | 0.060 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2006 | 38 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2001 | 1077 | 0.060 |
Why?
|
| Genes, T-Cell Receptor alpha | 1 | 2005 | 11 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2011 | 1504 | 0.060 |
Why?
|
| Energy Metabolism | 2 | 2024 | 937 | 0.060 |
Why?
|
| Killer Cells, Natural | 1 | 2009 | 481 | 0.060 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2005 | 48 | 0.060 |
Why?
|
| Diagnostic Techniques, Urological | 1 | 2005 | 5 | 0.060 |
Why?
|
| Caspase 7 | 1 | 2005 | 22 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3565 | 0.060 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2005 | 91 | 0.050 |
Why?
|
| Analysis of Variance | 3 | 2012 | 1302 | 0.050 |
Why?
|
| Fas Ligand Protein | 1 | 2005 | 61 | 0.050 |
Why?
|
| Tangier Disease | 1 | 1984 | 1 | 0.050 |
Why?
|
| Hypolipoproteinemias | 1 | 1984 | 2 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2010 | 799 | 0.050 |
Why?
|
| Case Management | 1 | 2005 | 68 | 0.050 |
Why?
|
| Thermosensing | 1 | 2004 | 12 | 0.050 |
Why?
|
| Microscopy, Electron | 3 | 1996 | 417 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 3448 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 157 | 0.050 |
Why?
|
| Vidarabine | 1 | 2004 | 32 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2008 | 795 | 0.050 |
Why?
|
| Microvilli | 1 | 2004 | 75 | 0.050 |
Why?
|
| Child, Preschool | 7 | 2016 | 12017 | 0.050 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 248 | 0.050 |
Why?
|
| Thoracic Surgery | 1 | 2006 | 143 | 0.050 |
Why?
|
| Young Adult | 3 | 2024 | 14437 | 0.050 |
Why?
|
| Hypertension, Renal | 2 | 2001 | 15 | 0.050 |
Why?
|
| Cytosol | 1 | 2004 | 213 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2006 | 264 | 0.050 |
Why?
|
| Nitrates | 2 | 2001 | 97 | 0.050 |
Why?
|
| Mycophenolic Acid | 1 | 2004 | 119 | 0.050 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2005 | 253 | 0.050 |
Why?
|
| Cytomegalovirus | 1 | 2004 | 172 | 0.050 |
Why?
|
| Myocardial Ischemia | 1 | 2005 | 287 | 0.050 |
Why?
|
| LLC-PK1 Cells | 3 | 2015 | 18 | 0.050 |
Why?
|
| Adenosine Triphosphate | 1 | 2006 | 500 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2007 | 537 | 0.050 |
Why?
|
| Nitric Oxide Synthase Type II | 5 | 2001 | 162 | 0.050 |
Why?
|
| Nitric Oxide Donors | 2 | 2001 | 19 | 0.050 |
Why?
|
| Stem Cell Transplantation | 1 | 2004 | 189 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 758 | 0.050 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2004 | 279 | 0.050 |
Why?
|
| Heart Defects, Congenital | 1 | 2011 | 941 | 0.050 |
Why?
|
| Leukocytes | 2 | 2001 | 301 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2010 | 919 | 0.050 |
Why?
|
| Solubility | 2 | 2000 | 240 | 0.050 |
Why?
|
| Denervation | 1 | 2002 | 27 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 288 | 0.050 |
Why?
|
| Receptors, Virus | 2 | 2013 | 95 | 0.040 |
Why?
|
| Complement Pathway, Alternative | 1 | 2003 | 121 | 0.040 |
Why?
|
| Copper Sulfate | 1 | 2001 | 8 | 0.040 |
Why?
|
| Apolipoprotein B-100 | 1 | 2001 | 13 | 0.040 |
Why?
|
| Sepharose | 2 | 1999 | 32 | 0.040 |
Why?
|
| Lipoxygenase | 1 | 2001 | 15 | 0.040 |
Why?
|
| Biopsy | 1 | 2005 | 1093 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2002 | 88 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2005 | 362 | 0.040 |
Why?
|
| Receptors, Drug | 1 | 2001 | 10 | 0.040 |
Why?
|
| Reference Values | 3 | 1995 | 800 | 0.040 |
Why?
|
| Prevalence | 1 | 2008 | 2889 | 0.040 |
Why?
|
| Aldosterone | 1 | 2001 | 42 | 0.040 |
Why?
|
| Neutralization Tests | 1 | 2001 | 76 | 0.040 |
Why?
|
| Temperature | 1 | 2004 | 638 | 0.040 |
Why?
|
| Mucoproteins | 1 | 2001 | 8 | 0.040 |
Why?
|
| Liver | 1 | 2010 | 1916 | 0.040 |
Why?
|
| Aging | 1 | 2012 | 1992 | 0.040 |
Why?
|
| Autophagosomes | 1 | 2021 | 20 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 1996 | 536 | 0.040 |
Why?
|
| Spironolactone | 1 | 2001 | 40 | 0.040 |
Why?
|
| Symporters | 1 | 2001 | 48 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2001 | 166 | 0.040 |
Why?
|
| Antihypertensive Agents | 2 | 2002 | 522 | 0.040 |
Why?
|
| Guanylate Cyclase | 1 | 2000 | 38 | 0.040 |
Why?
|
| Kinetics | 5 | 1999 | 1569 | 0.040 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2004 | 435 | 0.040 |
Why?
|
| Lung | 2 | 2011 | 4141 | 0.040 |
Why?
|
| Reoviridae Infections | 1 | 2001 | 54 | 0.040 |
Why?
|
| Detergents | 2 | 2000 | 43 | 0.040 |
Why?
|
| Antibody Specificity | 1 | 2000 | 180 | 0.040 |
Why?
|
| Octoxynol | 1 | 2000 | 12 | 0.040 |
Why?
|
| Myocarditis | 1 | 2001 | 102 | 0.040 |
Why?
|
| Insulin | 1 | 2011 | 2526 | 0.040 |
Why?
|
| Fibronectins | 2 | 1999 | 136 | 0.040 |
Why?
|
| Echocardiography | 2 | 2019 | 652 | 0.040 |
Why?
|
| Aspartic Acid | 1 | 1999 | 88 | 0.040 |
Why?
|
| Sympathectomy | 1 | 2019 | 6 | 0.040 |
Why?
|
| Models, Biological | 4 | 2012 | 1772 | 0.040 |
Why?
|
| Hepatocytes | 1 | 2019 | 224 | 0.030 |
Why?
|
| Infant | 4 | 2016 | 10195 | 0.030 |
Why?
|
| Choroid Neoplasms | 1 | 1998 | 9 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2013 | 5478 | 0.030 |
Why?
|
| Atrial Natriuretic Factor | 1 | 1997 | 55 | 0.030 |
Why?
|
| Growth Substances | 1 | 1997 | 138 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1997 | 38 | 0.030 |
Why?
|
| Cohort Studies | 3 | 2017 | 6099 | 0.030 |
Why?
|
| Apolipoprotein L1 | 1 | 2017 | 14 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 3980 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1997 | 82 | 0.030 |
Why?
|
| Hyperthermia, Induced | 1 | 1998 | 120 | 0.030 |
Why?
|
| Chromatography, Agarose | 1 | 1996 | 3 | 0.030 |
Why?
|
| Internationality | 1 | 2017 | 156 | 0.030 |
Why?
|
| Acidosis, Renal Tubular | 1 | 1996 | 4 | 0.030 |
Why?
|
| Cell Polarity | 1 | 1997 | 137 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2016 | 117 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2017 | 430 | 0.030 |
Why?
|
| Protein Conformation | 1 | 1999 | 943 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 1996 | 102 | 0.030 |
Why?
|
| Cathepsin L | 1 | 1995 | 9 | 0.030 |
Why?
|
| Metabolome | 1 | 2019 | 391 | 0.030 |
Why?
|
| Molecular Structure | 1 | 1996 | 488 | 0.030 |
Why?
|
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2015 | 22 | 0.030 |
Why?
|
| Particle Size | 1 | 1996 | 382 | 0.030 |
Why?
|
| Cell Adhesion | 3 | 2001 | 451 | 0.030 |
Why?
|
| Species Specificity | 1 | 2016 | 547 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 3 | 2001 | 49 | 0.030 |
Why?
|
| Visual Acuity | 1 | 1998 | 498 | 0.030 |
Why?
|
| Cattle | 2 | 2011 | 948 | 0.030 |
Why?
|
| Macrolides | 1 | 2014 | 68 | 0.030 |
Why?
|
| RNA Interference | 1 | 2016 | 477 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2012 | 848 | 0.030 |
Why?
|
| Lipopolysaccharides | 3 | 2002 | 863 | 0.030 |
Why?
|
| Pancreas | 1 | 1996 | 345 | 0.020 |
Why?
|
| United States | 1 | 2011 | 16313 | 0.020 |
Why?
|
| Transfection | 1 | 2016 | 930 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2016 | 294 | 0.020 |
Why?
|
| Myocardium | 1 | 2019 | 949 | 0.020 |
Why?
|
| Interferon-gamma | 2 | 2010 | 786 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 728 | 0.020 |
Why?
|
| Glomerular Mesangium | 1 | 1992 | 21 | 0.020 |
Why?
|
| Capillary Leak Syndrome | 1 | 2012 | 12 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 1992 | 70 | 0.020 |
Why?
|
| Ion Transport | 1 | 2012 | 62 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 110 | 0.020 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2012 | 29 | 0.020 |
Why?
|
| Gluconeogenesis | 1 | 2012 | 81 | 0.020 |
Why?
|
| North America | 1 | 2013 | 307 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 6011 | 0.020 |
Why?
|
| Least-Squares Analysis | 1 | 2012 | 73 | 0.020 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2012 | 17 | 0.020 |
Why?
|
| New Zealand | 1 | 2012 | 56 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2012 | 335 | 0.020 |
Why?
|
| Health | 1 | 2012 | 82 | 0.020 |
Why?
|
| Genotype | 1 | 2017 | 1875 | 0.020 |
Why?
|
| Phosphates | 1 | 2012 | 177 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2016 | 6543 | 0.020 |
Why?
|
| Graft Rejection | 1 | 1995 | 523 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2012 | 450 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2016 | 1018 | 0.020 |
Why?
|
| Melanoma | 1 | 1998 | 774 | 0.020 |
Why?
|
| Models, Molecular | 1 | 1996 | 1606 | 0.020 |
Why?
|
| Heat-Shock Proteins | 2 | 2004 | 140 | 0.020 |
Why?
|
| Cyclic GMP | 2 | 2001 | 90 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2011 | 62 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 626 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 528 | 0.020 |
Why?
|
| Molsidomine | 2 | 2001 | 5 | 0.020 |
Why?
|
| Linear Models | 1 | 2013 | 852 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 341 | 0.020 |
Why?
|
| Candida | 1 | 2010 | 46 | 0.020 |
Why?
|
| Longitudinal Studies | 2 | 2012 | 3029 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2012 | 627 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2013 | 566 | 0.020 |
Why?
|
| DNA Breaks | 1 | 2009 | 3 | 0.020 |
Why?
|
| DNA, Plant | 1 | 2009 | 17 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2017 | 2223 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2001 | 203 | 0.020 |
Why?
|
| Cell Shape | 1 | 2009 | 56 | 0.020 |
Why?
|
| HIV Infections | 1 | 2004 | 3235 | 0.020 |
Why?
|
| Monocytes | 1 | 2011 | 539 | 0.020 |
Why?
|
| Plant Proteins | 1 | 2009 | 111 | 0.020 |
Why?
|
| Aminocaproic Acid | 2 | 1999 | 4 | 0.020 |
Why?
|
| Isoelectric Focusing | 2 | 1984 | 30 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 2142 | 0.020 |
Why?
|
| Hepatorenal Syndrome | 1 | 2007 | 15 | 0.020 |
Why?
|
| Collagen | 2 | 2001 | 460 | 0.020 |
Why?
|
| Cell Death | 1 | 2009 | 383 | 0.020 |
Why?
|
| Regeneration | 1 | 2007 | 198 | 0.010 |
Why?
|
| Proteomics | 1 | 2012 | 1205 | 0.010 |
Why?
|
| Aneurysm, False | 1 | 2005 | 46 | 0.010 |
Why?
|
| Random Allocation | 1 | 2006 | 366 | 0.010 |
Why?
|
| Probability | 1 | 2006 | 309 | 0.010 |
Why?
|
| Annexin A5 | 1 | 2004 | 23 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2006 | 311 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 1984 | 39 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 1985 | 379 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 2004 | 25 | 0.010 |
Why?
|
| Autoradiography | 1 | 2004 | 66 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1984 | 332 | 0.010 |
Why?
|
| Osmotic Pressure | 1 | 2004 | 41 | 0.010 |
Why?
|
| Saline Solution, Hypertonic | 1 | 2004 | 43 | 0.010 |
Why?
|
| Epitopes | 1 | 1985 | 475 | 0.010 |
Why?
|
| Complement C9 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Tacrolimus | 1 | 2004 | 196 | 0.010 |
Why?
|
| Phentolamine | 1 | 2002 | 19 | 0.010 |
Why?
|
| Radiography | 1 | 2005 | 862 | 0.010 |
Why?
|
| Renin | 1 | 2002 | 33 | 0.010 |
Why?
|
| Complement Activation | 1 | 2006 | 401 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 2004 | 210 | 0.010 |
Why?
|
| Ultraviolet Rays | 2 | 2004 | 385 | 0.010 |
Why?
|
| Complement C3 | 1 | 2003 | 188 | 0.010 |
Why?
|
| Triazenes | 1 | 2001 | 6 | 0.010 |
Why?
|
| Sodium Chloride Symporters | 1 | 2001 | 1 | 0.010 |
Why?
|
| Solute Carrier Family 12, Member 3 | 1 | 2001 | 1 | 0.010 |
Why?
|
| Epinephrine | 1 | 2002 | 160 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2002 | 201 | 0.010 |
Why?
|
| Hydrolysis | 2 | 1999 | 197 | 0.010 |
Why?
|
| Liver Neoplasms | 2 | 1985 | 787 | 0.010 |
Why?
|
| Metabolism | 1 | 2001 | 44 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2001 | 80 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2004 | 297 | 0.010 |
Why?
|
| Uromodulin | 1 | 2001 | 22 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2004 | 396 | 0.010 |
Why?
|
| Electrolytes | 1 | 2001 | 54 | 0.010 |
Why?
|
| Blood Flow Velocity | 1 | 2002 | 422 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2000 | 88 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2001 | 72 | 0.010 |
Why?
|
| Nitroprusside | 1 | 2000 | 71 | 0.010 |
Why?
|
| Gels | 1 | 2001 | 86 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2001 | 163 | 0.010 |
Why?
|
| Body Fluids | 1 | 2001 | 71 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 2001 | 61 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1999 | 313 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2001 | 355 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2000 | 397 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2001 | 216 | 0.010 |
Why?
|
| HSP72 Heat-Shock Proteins | 1 | 1999 | 31 | 0.010 |
Why?
|
| Opossums | 1 | 1999 | 9 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1999 | 36 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1999 | 82 | 0.010 |
Why?
|
| Lipids | 1 | 1984 | 723 | 0.010 |
Why?
|
| Integrins | 1 | 1999 | 90 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 1999 | 158 | 0.010 |
Why?
|
| Solutions | 1 | 1999 | 160 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1999 | 154 | 0.010 |
Why?
|
| Phosphatidylcholines | 1 | 1999 | 131 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1999 | 138 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 1998 | 30 | 0.010 |
Why?
|
| Sodium | 1 | 1999 | 198 | 0.010 |
Why?
|
| Benzoates | 1 | 1998 | 51 | 0.010 |
Why?
|
| Pupil | 1 | 1998 | 22 | 0.010 |
Why?
|
| Indocyanine Green | 1 | 1998 | 43 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2001 | 562 | 0.010 |
Why?
|
| Imidazoles | 1 | 1998 | 247 | 0.010 |
Why?
|
| Fluorescein Angiography | 1 | 1998 | 195 | 0.010 |
Why?
|
| Polymers | 1 | 2001 | 486 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 1995 | 17561 | 0.010 |
Why?
|
| Plasminogen | 1 | 1996 | 27 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1996 | 10 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1996 | 185 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1996 | 25 | 0.010 |
Why?
|
| Stereoisomerism | 1 | 1996 | 103 | 0.010 |
Why?
|
| Palmitic Acid | 1 | 1996 | 40 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1998 | 342 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 1995 | 29 | 0.010 |
Why?
|
| Cell-Free System | 1 | 1995 | 54 | 0.010 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1996 | 82 | 0.010 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 1996 | 92 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 1996 | 187 | 0.010 |
Why?
|
| Potassium | 1 | 1996 | 152 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2000 | 781 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1995 | 296 | 0.010 |
Why?
|
| Protease Inhibitors | 2 | 1985 | 104 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 265 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 1319 | 0.010 |
Why?
|
| Protein Binding | 1 | 1996 | 2249 | 0.000 |
Why?
|
| Urea | 1 | 1969 | 85 | 0.000 |
Why?
|
| Lipoproteins | 1 | 1969 | 166 | 0.000 |
Why?
|
| Blood Proteins | 1 | 1969 | 239 | 0.000 |
Why?
|
| Apolipoprotein A-II | 1 | 1985 | 5 | 0.000 |
Why?
|
| Culture Media | 1 | 1984 | 161 | 0.000 |
Why?
|
| Peptides | 1 | 1969 | 1003 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1985 | 901 | 0.000 |
Why?
|
| Freeze Etching | 1 | 1977 | 1 | 0.000 |
Why?
|
| Phospholipases | 1 | 1977 | 14 | 0.000 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1977 | 196 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1977 | 153 | 0.000 |
Why?
|
| Electrophoresis, Disc | 1 | 1969 | 3 | 0.000 |
Why?
|
| Immunodiffusion | 1 | 1969 | 13 | 0.000 |
Why?
|
| Methods | 1 | 1969 | 68 | 0.000 |
Why?
|
| Chemistry | 1 | 1969 | 41 | 0.000 |
Why?
|
| Immune Sera | 1 | 1969 | 77 | 0.000 |
Why?
|
| Chemical Phenomena | 1 | 1969 | 77 | 0.000 |
Why?
|
| Blood Group Antigens | 1 | 1969 | 15 | 0.000 |
Why?
|
| Spectrophotometry | 1 | 1969 | 58 | 0.000 |
Why?
|
| Ultracentrifugation | 1 | 1969 | 51 | 0.000 |
Why?
|
| Chromatography, Gel | 1 | 1969 | 131 | 0.000 |
Why?
|
| Spectrum Analysis | 1 | 1969 | 85 | 0.000 |
Why?
|
| Dextrans | 1 | 1969 | 84 | 0.000 |
Why?
|
| Rabbits | 1 | 1969 | 654 | 0.000 |
Why?
|
| Antigens | 1 | 1969 | 348 | 0.000 |
Why?
|
| Amino Acids | 1 | 1969 | 519 | 0.000 |
Why?
|